Shinhiti Morita1,2, Dalísio De Santi Neto3, Flávio Hiroshi Ananias Morita4, Nina Kimie Morita5, Suzana Margareth Ajeje Lobo6. 1. Surgery Department, Bariatric and Metabolic Surgery Services, Hospital de Base, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil. s-morita@uol.com.br. 2. , Rua Las Vegas 444, Bairro Debora Cristina, 15093-010, São José do Rio Preto, SP, Brazil. s-morita@uol.com.br. 3. Pathology Department, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil. dalisius@gmail.com. 4. Surgery Department, Bariatric and Metabolic Surgery Services, Hospital de Base, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil. flaviomorita@hotmail.com. 5. Surgery Department, Bariatric and Metabolic Surgery Services, Hospital de Base, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil. ninakm1994@hotmail.com. 6. Division of Intensive Care, Internal Medicine Department, Hospital de Base, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil. suzanalobo@gmail.com.
Abstract
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) associated with obesity comprises pathological changes ranging from steatosis to steatohepatitis; these can evolve to cirrhosis and hepatocellular carcinoma. OBJECTIVES: The objectives of this study are to assess the prevalence of and predictive markers for steatohepatitis in obese patients undergoing bariatric surgery. METHODS: A prospective study of 184 morbidly obese patients undergoing bariatric surgery formed the study cohort. Patients taking potentially hepatotoxic medications and those with viral diseases and a history of excessive alcohol consumption were excluded. Liver biopsies were performed during surgery with a "Trucut" needle. Patients were classified into the following groups according to the histopathological findings: normal, steatosis, mild steatohepatitis, and moderate-severe steatohepatitis. Factors associated with steatohepatitis were evaluated using logistic regression. p values <0.05 were considered significant. RESULTS: The prevalence of NAFLD was 84 % (steatosis, 22.0 %; mild steatohepatitis, 30.8 %; moderate-severe steatohepatitis, 32.0 %). Independent predictive factors for steatohepatitis were age (odds ratio (OR), 1.05; 95 % confidence interval (CI), 1.01-1.09; p = 0.011), waist circumference (OR, 1.03; 95 % CI, 1.00-1.06; p = 0.021), serum alanine aminotransferase (ALT) levels (OR, 1.04; 95 % CI, 1.01-1.08; p = 0.005), and serum triglyceride levels (OR, 1.01; 95 % CI, 1.00-1.01; p = 0.042). Score values for each predictor were derived from regression coefficients and odds ratio, and a total (risk) score was obtained from the sum of the points to evaluate the probability of having steatohepatitis. CONCLUSION: Age, waist circumference, serum ALT levels, and serum triglyceride levels are efficient and non-invasive predictive markers for the diagnosis and management of steatohepatitis in morbidly obese patients.
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) associated with obesity comprises pathological changes ranging from steatosis to steatohepatitis; these can evolve to cirrhosis and hepatocellular carcinoma. OBJECTIVES: The objectives of this study are to assess the prevalence of and predictive markers for steatohepatitis in obesepatients undergoing bariatric surgery. METHODS: A prospective study of 184 morbidly obesepatients undergoing bariatric surgery formed the study cohort. Patients taking potentially hepatotoxic medications and those with viral diseases and a history of excessive alcohol consumption were excluded. Liver biopsies were performed during surgery with a "Trucut" needle. Patients were classified into the following groups according to the histopathological findings: normal, steatosis, mild steatohepatitis, and moderate-severe steatohepatitis. Factors associated with steatohepatitis were evaluated using logistic regression. p values <0.05 were considered significant. RESULTS: The prevalence of NAFLD was 84 % (steatosis, 22.0 %; mild steatohepatitis, 30.8 %; moderate-severe steatohepatitis, 32.0 %). Independent predictive factors for steatohepatitis were age (odds ratio (OR), 1.05; 95 % confidence interval (CI), 1.01-1.09; p = 0.011), waist circumference (OR, 1.03; 95 % CI, 1.00-1.06; p = 0.021), serum alanine aminotransferase (ALT) levels (OR, 1.04; 95 % CI, 1.01-1.08; p = 0.005), and serum triglyceride levels (OR, 1.01; 95 % CI, 1.00-1.01; p = 0.042). Score values for each predictor were derived from regression coefficients and odds ratio, and a total (risk) score was obtained from the sum of the points to evaluate the probability of having steatohepatitis. CONCLUSION: Age, waist circumference, serum ALT levels, and serum triglyceride levels are efficient and non-invasive predictive markers for the diagnosis and management of steatohepatitis in morbidly obesepatients.
Authors: Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley Journal: Hepatology Date: 2010-09 Impact factor: 17.425
Authors: David E Kleiner; Paul D Berk; Jesse Y Hsu; Anita P Courcoulas; David Flum; Saurabh Khandelwal; John Pender; Alfons Pomp; James Roerig; Laura L Machado; Bruce M Wolfe; Steven H Belle Journal: Semin Liver Dis Date: 2014-04-29 Impact factor: 6.115
Authors: Helma P Cotrim; Edison R Parise; Claudia P M S Oliveira; Natalhie Leite; Ana Martinelli; João Galizzi; Rita de Cássia Silva; Angelo Mattos; Leila Pereira; Waldir Amorim; Claúdia Ivantes; Francisco Souza; Marcelo Costa; Lizomar Maia; Mário Pessoa; Frederico Oliveira Journal: Ann Hepatol Date: 2011 Jan-Mar Impact factor: 2.400
Authors: Brenda W J H Penninx; Barbara J Nicklas; Anne B Newman; Tamara B Harris; Bret H Goodpaster; Suzanne Satterfield; Nathalie de Rekeneire; Kristine Yaffe; Marco Pahor; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-20 Impact factor: 6.053
Authors: Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Paul E O'Brien; Wendy A Brown Journal: Obes Surg Date: 2017-01 Impact factor: 4.129
Authors: Cristiane A Villela-Nogueira; Nathalie C Leite; Claudia R L Cardoso; Gil F Salles Journal: Int J Mol Sci Date: 2016-04-20 Impact factor: 5.923
Authors: Ahmad Hassan Ali; Alhareth Al Juboori; Gregory F Petroski; Alberto A Diaz-Arias; Majid M Syed-Abdul; Andrew A Wheeler; Rama R Ganga; James B Pitt; Nicole M Spencer; Ghassan M Hammoud; R Scott Rector; Elizabeth J Parks; Jamal A Ibdah Journal: J Clin Med Date: 2022-02-23 Impact factor: 4.964